Analysed VIVOS INC (RDGL:OTCMKTS) News Sources
Vivos Inc. Announces Receipt of Washington State Radioactive Materials License for IsoPet® Manufacturing
11-06-2026
yahoo.com
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
11-06-2026
yahoo.com
Vivos Receives Washington Radioactive Materials License for IsoPet Manufacturing, Enabling Domestic Production Expansion (RDGL)
11-06-2026
advfn.com
Vivos Therapeutics and Streeterville Extend Timeframe of Strategic Financing Agreement and Reaffirm Commitment to Convert Debt Into Common Stock and Perpetual Preferred Equity
22-06-2026
yahoo.com
Vivos’ Vida® Appliance Shows Statistically Significant Improvement in Insomnia Severity in 100% of Study Participants
30-06-2026
yahoo.com
Vivos Inc. (OTCQB: RDGL) Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study for RadioGel® Precision Radionuclide Therapy™
06-07-2026
yahoo.com
Vivos Inc. (OTCQB: RDGL) Reports Second Quarter 2026 Progress and Corporate Update
27-07-2026
yahoo.com
Vivos Reports FDA IDE Approval and Expands Precision Radionuclide Therapy Programs
27-07-2026
advfn.com
What is the current price of VIVOS INC (RDGL:OTCMKTS)?
The current price of VIVOS INC (RDGL:OTCMKTS) is $0.05737.
VIVOS INC (RDGL:OTCMKTS) absolute price change since previous trading day?
The absolute price change of VIVOS INC (RDGL:OTCMKTS) since the previous trading day is $-0.00201.
VIVOS INC (RDGL:OTCMKTS) percentage price change since previous trading day?
The percentage price change of VIVOS INC (RDGL:OTCMKTS) since the previous trading day is -3.385%.
What is the most recent average sentiment score for VIVOS INC (RDGL:OTCMKTS)?
The most recent average sentiment score for VIVOS INC (RDGL:OTCMKTS) is 68 out of 100.
What is the most recent average sentiment for VIVOS INC (RDGL:OTCMKTS)?
The most recent sentiment for VIVOS INC (RDGL:OTCMKTS) is .
SEC-8K** Filing Available For VIVOS INC (RDGL:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.